Transo Pharm Cannabidiol Header Transo Pharm Cannabidiol Header

X

Find Radio Compass News for Cannabidiol

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

0

Australia

Australia

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

SERVICES

0

https://pharmaphorum.com/news/harmony-buys-cannabidiol-firm-zynerba-200m-deal

PHARMAPHORUM
16 Aug 2023

https://www.prnewswire.com/news-releases/fda-concludes-that-existing-regulatory-frameworks-for-foods-and-supplements-are-not-appropriate-for-cannabidiol-will-work-with-congress-on-a-new-way-forward-301731634.html

PR NEWSWIRE
26 Jan 2023

https://www.transopharm.com/blog/transo-pharm-establishes-relationship-with-22nd-century-group-as-their-partner-for-global-sales-marketing-and-distribution-of-pharmaceutical-grade-cannabinoid-apis

PRESS RELEASE
25 Jan 2023

https://www.fiercepharma.com/pharma/jazz-pharmaceuticals-sues-generics-makers-over-its-cannabis-derived-epilepsy-drug

Zoey Becker FIERCE PHARMA
06 Jan 2023

https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-cannabidiol-oral-solution-25601.pdf

FDA
14 Dec 2022

https://www.businesswire.com/news/home/20221214005204/en

BUSINESSWIRE
14 Dec 2022

https://investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-presents-new-findings-caregiver-survey

PRESS RELEASE
05 Dec 2022

https://www.fiercepharma.com/pharma/puretech-readies-oral-cbd-capsule-clinic-challenge-jazzs-epidiolex

Nick Paul Taylor FIERCEPHARMA
01 Dec 2022

https://www.globenewswire.com/news-release/2022/11/15/2555997/36775/en/Zynerba-Pharmaceuticals-Announces-European-Commission-Has-Granted-Orphan-Drug-Designation-for-Zygel-in-22q11-2-Deletion-Syndrome.html

GLOBENEWSWIRE
15 Nov 2022

https://www.zynerba.com/zynerba-pharmaceuticals-announces-issuance-of-new-u-s-patent-for-zygel-for-the-treatment-of-22q11-2-deletion-syndrome/

ZYNERBA
02 Nov 2022

https://www.prnewswire.com/news-releases/isosceles-pharmaceuticals-signs-non-binding-letter-of-intent-with-a-strategic-partner-for-phase-1-development-of-its-proprietary-synthetic-cannabidiol-intravenous-product-301662397.html

PRNEWSWIRE
31 Oct 2022

https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-initiation-of-phase-3-trial-evaluating-epidiolexepidyolex-cannabidiol-for-patients-with-epilepsy-with-myoclonic-atonic-seizures-301608430.html

PRNEWSWIRE
18 Aug 2022

https://www.businesswire.com/news/home/20220815005046/en

BUSINESSWIRE
15 Aug 2022

https://www.globenewswire.com/news-release/2022/05/05/2436669/36215/en/InMed-to-Supply-Rare-Cannabinoids-to-Radicle-Science-s-Radicle-Energy-Study-to-Assess-the-Health-Effects-of-THCV.html

GLOBENEWSWIRE
05 May 2022

https://www.prnewswire.com/news-releases/mgc-pharmaceuticals-enters-partnership-with-sciensus-rare-for-distribution-of-cannabinoids-to-treat-refractory-epilepsy-dementia-and-alzheimers-in-the-eu-and-uk-301517261.html

PRNEWSWIRE
05 Apr 2022

https://www.businesswire.com/news/home/20220325005259/en

BUSINESSWIRE
25 Mar 2022

https://www.accesswire.com/693001/Panacea-Life-Sciences-Inc-Partners-with-European-CBD-Market-Leader-Chanelle-McCoy-Health-for-US-Launch

ACCESSWIRE
15 Mar 2022

https://www.businesswire.com/news/home/20220311005040/en

BUSINESSWIRE
11 Mar 2022

https://www.accesswire.com/692087/Can-B-Corp-and-American-Development-Partners-Agree-to-Finance-and-Develop-CBD-Lounges

ACCESSWIRE
08 Mar 2022

https://www.globenewswire.com/news-release/2022/03/02/2395415/0/en/Artelo-Biosciences-Receives-Notice-of-Allowance-for-Method-of-Use-Patent-in-the-United-States-for-ART12-11-a-Proprietary-Cocrystal-of-Cannabidiol.html

GLOBENEWSWIRE
02 Mar 2022

https://www.prnewswire.com/news-releases/brains-bioceutical-initiates-clinical-trial-agreement-to-tackle-opioid-addiction-301478375.html

PRNEWSWIRE
09 Feb 2022

https://www.accesswire.com/687077/Love-Hemp-Group-PLC-Announces-Directorate-Changes

ACCESSWIRE
03 Feb 2022

https://www.prnewswire.com/news-releases/canntab-announces-closing-of-convertible-debenture-private-placement-warrant-expiry-extension-and-corporate-update-301473454.html

PRNEWSWIRE
01 Feb 2022

https://www.globenewswire.com/news-release/2022/02/01/2376728/0/en/Skye-Bioscience-Reports-Potential-Neuroprotective-Benefit-of-SBI-100-In-Preclinical-Glaucoma-Model.html

GLOBENEWSWIRE
01 Feb 2022

https://www.globenewswire.com/news-release/2022/01/19/2369218/36215/en/InMed-Launches-Cannabicitran-CBT-Expanding-its-Rare-Cannabinoid-Portfolio-for-the-Health-and-Wellness-Sector.html

GLOBENEWSWIRE
19 Jan 2022

https://www.globenewswire.com/news-release/2022/01/14/2367137/0/en/Avicanna-Enters-Master-Supply-Agreement-with-Chilean-Pharmaceutical-Pioneer-Knop-Laboratorios-S-A.html

GLOBENEWSWIRE
14 Jan 2022

https://www.pharmacompass.com/pdf/news/scisparc-issued-us-patent-for-its-core-technology-that-treats-central-nervous-systems-disorders-1643013825.pdf

PRESS RELEASE
04 Jan 2022

https://www.businesswire.com/news/home/20220104005104/en

BUSINESSWIRE
04 Jan 2022

https://www.globenewswire.com/news-release/2021/12/28/2358591/0/en/MALACHITE-INNOVATIONS-ANNOUNCES-TWO-GRANTED-U-S-PATENTS-AND-NEW-PCT-PATENT-FILING.html

GLOBENEWSWIRE
28 Dec 2021

http://www.pharmabiz.com/NewsDetails.aspx?aid=144689&sid=2

PHARMABIZ
17 Dec 2021

https://www.businesswire.com/news/home/20211214005476/en

BUSINESSWIRE
14 Dec 2021

https://www.prnewswire.com/news-releases/vpr-brands-announces-favorable-settlement-of-a-recently-filed-patent-infringement-case-301439466.html

PRNEWSWIRE
07 Dec 2021

http://www.pharmabiz.com/NewsDetails.aspx?aid=144448&sid=2

PHARMABIZ
06 Dec 2021

https://www.prnewswire.com/news-releases/cibdol-launches-revolutionary-cbd-oil-formula-301437403.html

PRNEWSWIRE
05 Dec 2021

https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-present-from-expanding-neuroscience-portfolio-epidiolex-cannabidiol-oral-solution-data-at-the-2021-american-epilepsy-society-annual-meeting-301434871.html

PRNEWSWIRE
01 Dec 2021

https://www.biospace.com/article/releases/enveric-biosciences-announces-positive-preclinical-data-for-ev102-radiodermatitis-drug-candidate/?s=71

BIOSPACE
18 Nov 2021

https://www.businesswire.com/news/home/20211117005342/en

BUSINESSWIRE
17 Nov 2021

https://www.prnewswire.com/news-releases/aurora-builds-on-a-decade-of-global-leadership-in-plant-genetics-with-the-launch-of-occo-301425002.html

PRNEWSWIRE
16 Nov 2021

https://www.prnewswire.com/news-releases/aurora-cannabis-announces-fiscal-2022-first-quarter-results-301420228.html

PRNEWSWIRE
09 Nov 2021

https://www.prnewswire.com/news-releases/curebase-level-announce-clinical-trial-to-determine-whether-cannabinoids-can-help-veterans-sleep-better-301415517.html

PRNEWSWIRE
03 Nov 2021

https://www.businesswire.com/news/home/20211027005178/en

BUSINESSWIRE
27 Oct 2021

https://www.chron.com/news/houston-texas/article/Texas-Delta-8-ban-faces-new-legal-challenge-from-16565882.php

Jay R. Jordan CHRON
26 Oct 2021

https://www.prnewswire.com/news-releases/nalu-bio-secures-global-supply-chain-to-chemically-synthesize-cbd-301407771.html

PRNEWSWIRE
26 Oct 2021

https://www.clinicaltrialsarena.com/special-focus/covid-19/cbd-covid-19-cardiol-trial/

Reynald Castaneda CLINICALTRIALSARENA
07 Oct 2021

https://www.businesswire.com/news/home/20211005005113/en

BUSINESSWIRE
05 Oct 2021

https://www.prnewswire.com/news-releases/cannabics-announces-new-corporate-logo-new-website-and-new-company-presentation-301388844.html

PRNEWSWIRE
30 Sep 2021

https://www.businesswire.com/news/home/20210929005209/en/ANANDA-Scientific-and-David-Geffen-School-of-Medicine-UCLA-Announce-Clinical-Trial-Utilizing-Liquid-StructureTM-Cannabidiol-CBD-for-the-Treatment-of-Opioid-Use-Disorder-OUD

BUSINESSWIRE
29 Sep 2021

https://www.globenewswire.com/news-release/2021/09/24/2302894/0/en/Avicanna-Files-US-Patent-Application-for-a-Novel-Cannabinoid-Formulation-in-Reducing-Incidence-of-Seizures-and-Sudden-Unexpected-Death-in-Epilepsy.html

GLOBENEWSWIRE
24 Sep 2021

https://www.businesswire.com/news/home/20210920005202/en

BUSINESSWIRE
20 Sep 2021

https://www.globenewswire.com/news-release/2021/08/31/2289145/0/en/Tauriga-Sciences-Inc-Initiates-Clinical-Trial-to-Examine-the-Effects-of-Cannabidiol-Doses-on-Pregnant-Women-with-Diagnosis-of-Hyperemesis-Gravidarum.html

GLOBENEWSWIRE
31 Aug 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY